MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
HSGP is engaged closely with the USFDA and is committed to address the OAI observations through planned remediation measures
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
Subscribe To Our Newsletter & Stay Updated
